Treatment of Vaginal Yeast Infection
For uncomplicated vaginal yeast infections, use either a single 150 mg oral dose of fluconazole OR a short course of topical azole therapy (3-7 days), as both achieve equivalent cure rates of 80-90%. 1
First-Line Treatment Options
Oral Therapy
- Fluconazole 150 mg as a single oral dose is the most convenient option for uncomplicated vulvovaginal candidiasis 1, 2
- Achieves clinical cure or improvement in 94% of patients at 14-day evaluation 3
- Therapeutic concentrations in vaginal secretions are rapidly achieved and sustained 4
- Well-tolerated with mostly mild, transient gastrointestinal side effects 4, 5
Topical Intravaginal Therapy
Multiple equally effective options are available over-the-counter and by prescription 1:
Short-course regimens (3 days):
- Butoconazole 2% cream 5g intravaginally 1
- Clotrimazole 100 mg vaginal tablet, two tablets 1
- Miconazole 200 mg vaginal suppository 1
- Terconazole 0.8% cream 5g intravaginally 1
- Terconazole 80 mg vaginal suppository 1
Single-dose regimens:
Longer regimens (7-14 days):
- Clotrimazole 1% cream 5g intravaginally for 7-14 days 1, 6
- Miconazole 2% cream 5g intravaginally for 7 days 1
Complicated Vulvovaginal Candidiasis
For complicated infections (severe symptoms, recurrent disease, non-albicans species, immunocompromised host), use extended therapy: 1
- Fluconazole 150 mg every 72 hours for 3 doses (total of 3 doses over 6 days) 1, 7
- OR topical azole therapy for 7-14 days 1
- The 2-dose fluconazole regimen achieves significantly higher clinical cure rates in severe vaginitis (P=0.015) 7
Recurrent Vulvovaginal Candidiasis
For recurrent infections (≥4 episodes per year): 1
- Induction phase: Topical agent or oral fluconazole for 10-14 days 1
- Maintenance phase: Fluconazole 150 mg once weekly for at least 6 months 1
Special Populations
Pregnancy
- Fluconazole can be used in pregnancy at 2g single dose for trichomoniasis per older guidelines 1
- However, for vaginal candidiasis in pregnancy, topical azole therapy is generally preferred 2
- Use birth control during fluconazole treatment and for 1 week after final dose if pregnancy is possible 2
HIV-Positive Women
- Treatment should not differ based on HIV status 1
- Identical response rates are anticipated for HIV-positive and HIV-negative women 1
Important Caveats
Confirm diagnosis before treatment: 1
- Wet mount with 10% KOH to demonstrate yeast or pseudohyphae 1
- Normal vaginal pH (≤4.5) 1
- 10-20% of asymptomatic women harbor Candida, so culture alone without symptoms should not prompt treatment 1
Self-treatment limitations: 1
- Over-the-counter preparations should only be used by women previously diagnosed with vaginal yeast infection who have recurrence of the same symptoms 1
- Seek medical care if symptoms persist after OTC treatment or recur within 2 months 1, 8
Non-albicans Candida species: 1, 7
- C. krusei responds to all topical antifungal agents but is fluconazole-resistant 1
- C. glabrata is problematic and frequently azole-resistant 1, 7
- For C. glabrata: Consider boric acid 600mg in gelatin capsules intravaginally, nystatin suppositories, or compounded 17% flucytosine cream ± 3% amphotericin B cream 1
Drug interactions with fluconazole: 2